Bone Cancer Drug Targets Tumors, Spares Other Organs

News   Jul 16, 2017 | Original story from University of Texas M. D. Anderson Cancer Center

 
Bone Cancer Drug Targets Tumors, Spares Other Organs
 
 
 

RELATED ARTICLES

Novel Chemistry Technique Simplifies Late-Stage Modification of Drug Compounds

News

Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.

READ MORE

Advanced Prostate Cancer: EMA Approves Abiraterone Combined With Hormone Therapy as First-line Treatment

News

The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer.

READ MORE

Cancer Cells Prevent Immune Cells from Producing Cancer Killing Chemicals

News

Researchers have identified a substance released by pancreatic cancer cells that protects them from attack by immune cells called macrophages

READ MORE

 

Comments | 1 ADD COMMENT

Sandhya Reddy | Oct 10, 2017

Hi, Nice blog and you explained very well in this article. Thanks for sharing this article. http://fightbonetumors.com/


Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE